ETOPOPHOS PRESERVATIVE FREE

LOE Approaching

etoposide phosphate

NDAINJECTIONINJECTABLE
Approved
Feb 1998
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3

Mechanism of Action

12.1 Mechanism of Action Etoposide phosphate is a prodrug that is converted to its active moiety, etoposide, by dephosphorylation. Etoposide causes the induction of DNA strand breaks by an interaction with DNA-topoisomerase II or the formation of free radicals, leading to cell cycle arrest,…

Indications (1)

Clinical Trials (3)

NCT05364424Phase 1Completed

A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma

Started Nov 2022
43 enrolled
Diffuse Large B-Cell Lymphoma (DLBCL)
NCT00303849Phase 1/2Completed

Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors

Started Sep 2005
33 enrolled
Anaplastic OligoastrocytomaAnaplastic OligodendrogliomaMixed Glioma+1 more
NCT00074178Phase 2Completed

Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma

Started Jan 2000
22 enrolled
Lymphoma